STRO - ストゥロ・バイオファ―マ （Sutro Biopharma Inc.）

In Tuesday’s session, Sutro Biopharma Inc. (NASDAQ:STRO) marked $8.02 per share, down from $8.08 in the previous session. While Sutro Biopharma Inc. has underperformed by -0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -46.10%, with highs and lows ranging from $15.67 to […]

Sutro Biopharma Inc. (NASDAQ:STRO) price on Friday, December 23, fall -2.28% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.87. A look at the stock’s price movement, the close in the last trading session was $7.03, moving within a range at $6.665 and $7.13. The beta value … Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? Read More »

As of Tuesday, Sutro Biopharma Inc.’s (NASDAQ:STRO) stock closed at $7.41, up from $7.39 the previous day. While Sutro Biopharma Inc. has overperformed by 0.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -52.35%, with highs and lows ranging from $16.60 to $3.33, […]

Sutro Biopharma Inc. (NASDAQ:STRO)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.01. At the close of trading, the stock’s price was $7.10, to imply a decrease of -4.31% or -$0.32 in intraday trading. The STRO share’s 52-week high remains $16.60, putting it -133.8% down since that … Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? Read More »

The following slide deck was published by Sutro Biopharma, Inc.

In Tuesday’s session, Sutro Biopharma Inc. (NASDAQ:STRO) marked $8.02 per share, down from $8.08 in the previous session. While Sutro Biopharma Inc. has underperformed by -0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -46.10%, with highs and lows ranging from $15.67 to […]

Sutro Biopharma Inc. (NASDAQ:STRO) price on Friday, December 23, fall -2.28% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.87. A look at the stock’s price movement, the close in the last trading session was $7.03, moving within a range at $6.665 and $7.13. The beta value … Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? Read More »

As of Tuesday, Sutro Biopharma Inc.’s (NASDAQ:STRO) stock closed at $7.41, up from $7.39 the previous day. While Sutro Biopharma Inc. has overperformed by 0.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -52.35%, with highs and lows ranging from $16.60 to $3.33, […]

Sutro Biopharma Inc. (NASDAQ:STRO)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.01. At the close of trading, the stock’s price was $7.10, to imply a decrease of -4.31% or -$0.32 in intraday trading. The STRO share’s 52-week high remains $16.60, putting it -133.8% down since that … Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? Read More »

The following slide deck was published by Sutro Biopharma, Inc.

In last trading session, Sutro Biopharma Inc. (NASDAQ:STRO) saw 1.6 million shares changing hands with its beta currently measuring 1.04. Company’s recent per share price level of $5.21 trading at -$0.03 or -0.57% at ring of the bell on the day assigns it a market valuation of $243.36M. That closing price of STRO’s stock is … Sutro Biopharma Inc. (NASDAQ:STRO) 21.16% Up Over A Week, Can The Stock Hit Well Above $0.91? Read More »

Astellas Pharma Inc (OTC: ALPMF ) and Sutro Biopharma Inc (NASDAQ: STRO ) announced a strategic collaboration and licensing agreement focused on the discovery and development of immunostimulatory antibody-drug conjugates (iADC). iADCs are a next-generation modality for treating cancer and are designed to boost anti-cancer activity. They offer potential new options for patients who do not … Full story available on Benzinga.com

During the last session, Sutro Biopharma Inc. (NASDAQ:STRO)’s traded shares were 0.59 million, with the beta value of the company hitting 1.18. At the end of the trading day, the stock’s price was $4.49, reflecting an intraday gain of 4.18% or $0.18. The 52-week high for the STRO share is $23.70, that puts it down … Boom Or Bust? Where Will Sutro Biopharma Inc. (NASDAQ: STRO) Stock Go Next? Read More »

Sutro Biopharma Inc (STRO) shares closed today at 1.6% above its 52 week low of $14.03, giving the company a market cap of $659M. The stock is currently down 34.4% year-to-date, down 35.5% over the past 12 months, and down 6.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 36.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 257.5% The company's stock price performance over the past 12 months lags the peer average by 200.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Sutro Biopharma Inc (STRO) shares closed 0.1% lower than its previous 52 week low, giving the company a market cap of $680M. The stock is currently down 32.3% year-to-date, down 33.6% over the past 12 months, and down 3.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 36.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 195.0% The company's stock price performance over the past 12 months lags the peer average by 139.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.